🧬 Coming soon: Rapid Microbial Screen.Sterility screening results in hours, not 14 days.Get notified →
PuriLab Analytical
COA/TZ-2026-050Verified
Save as PDF

Certificate of Analysis

PuriLab Analytical

Tirzepatide 5 mg

TZ-2026-050Lot TR5WT-102026Analyzed November 11, 2026

Timeline

Ordered
October 30, 2026
Received
November 10, 2026
Analyzed
November 11, 2026

Sample

Name
Tirzepatide 5 mg
Expected
Tirzepatide
Amount
3 vials (same product, conformity), lyophilized powder

Testing

Client
Bankroll Aminos
Test type
Content & purity, conformity
Method
HPLC-UV
Content, how much is in it
5.31mg
Label claim: 5 mg
Purity, how clean it is
99.3%
Average of 3 vials from the same lot, HPLC-UV peak area
Conformity
CONFORMS
All 3 vials match. Content and purity above are the average of the three. Chromatogram shows vial 1.
VialContentPurity
Vial 15.37 mg98.0%
Vial 25.40 mg>99.9%
Vial 35.16 mg>99.9%
Average5.31 mg99.3%

Chromatogram

HPLC-UV

mAU-10001002000481216202428Retention time (min)19.47
19.47 min, Tirzepatide, 98.0% (vial 1)

Analyst Comments

White lyophilized powder, white-cap vials, received sealed.

Analyst Signature

Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 11, 2026

Verification Code

TZ-B8VJ-XJZV
Verify at purilab.org/verify/TZ-B8VJ-XJZV

Scan to Verify

TZ-B8VJ-XJZV

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analyticaladmin@purilab.org
Page 1 of 1